journal article·2016-04-27

Size-Shifting Micelle Nanoclusters Based on a Cross-Linked and pH-Sensitive Framework for Enhanced Tumor Targeting and Deep Penetration Features

Huihui Liang, Xiaoqing Ren, Jianghui Qian, Xiulei Zhang, Lin Meng, Xiaofei Wang, Lei Li, Xiaoling Fang, Xianyi Sha

Publisher page

Abstract

The antitumor effect of chemotherapeutics loaded micelles mainly depends on two aspects: the accumulation in the tumor region and the penetration into the tumor interior. These two processes have different demands on particle size. The optimal particle size for enhanced permeability and retention (EPR) is commonly believed to be around 100 nm, while much smaller size is desired for deeper penetration into the tumor interior. To address these two different requirements, we constructed size-shifting micelle nanoclusters (MNC) based on a cross-linked framework interspersed with micelles. The particle size of the micelles was 14.6 ± 0.8 nm and increased to 104.2 ± 8.1 nm after the MNC were formed, leading to an effective utilization of the EPR effect. MNC were shifted to independent micelles in lysosomes, so that a more favorable particle size for penetration could be realized. The results of antitumor growth in vivo demonstrated that size-shifting MNC were more beneficial for tumor therapy than micelles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Smart Drug Delivery, Ministry of Education & PLA, School of Pharmacy, Fudan University, Lane 826, Zhangheng Road, Shanghai 201203, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (47)

Show source-provided references
1. 10.1007/s00018-004-4153-510.1007/s00018-004-4153-5 ↗
2. 10.1016/S0014-5793(03)01085-810.1016/S0014-5793(03)01085-8 ↗
3. 10.1634/theoncologist.8-5-41110.1634/theoncologist.8-5-411 ↗
4. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
5. 10.1016/S0168-3659(01)00275-910.1016/S0168-3659(01)00275-9 ↗
6. 10.1016/j.addr.2010.05.00110.1016/j.addr.2010.05.001 ↗
7. 10.1073/pnas.101815410810.1073/pnas.1018154108 ↗
8. 10.1002/anie.20100314210.1002/anie.201003142 ↗
9. 10.1016/j.bpj.2010.08.06510.1016/j.bpj.2010.08.065 ↗
10. Yuan F. · Cancer Res. · 1995 · 55 · 3752
11. Moghimi S. M. · Pharmacol Rev. · 2001 · 53 · 28310.1016/S0031-6997(24)01494-7 ↗
12. 10.1021/mp800049w10.1021/mp800049w ↗
13. 10.1016/S0378-5173(01)00986-310.1016/S0378-5173(01)00986-3 ↗
14. 10.1054/bjoc.1999.117110.1054/bjoc.1999.1171 ↗
15. 10.1021/nl900031y10.1021/nl900031y ↗
16. Yuan F. · Cancer Res. · 1994 · 54 · 3352
17. 10.1038/nm87910.1038/nm879 ↗
18. 10.1073/pnas.101889210810.1073/pnas.1018892108 ↗
19. 10.1158/0008-5472.CAN-05-224210.1158/0008-5472.CAN-05-2242 ↗
20. 10.1039/C5NR05264E10.1039/C5NR05264E ↗
21. 10.1002/cbin.1045910.1002/cbin.10459 ↗
22. 10.1002/adhm.20150062210.1002/adhm.201500622 ↗
23. 10.1016/j.jconrel.2015.10.00610.1016/j.jconrel.2015.10.006 ↗
24. 10.1073/pnas.101838210810.1073/pnas.1018382108 ↗
25. 10.1016/j.biomaterials.2015.05.00610.1016/j.biomaterials.2015.05.006 ↗
26. 10.1039/C5NR01408E10.1039/C5NR01408E ↗
27. 10.1021/ja211888a10.1021/ja211888a ↗
28. 10.1002/anie.20090044110.1002/anie.200900441 ↗
29. 10.1016/S0169-409X(01)00245-910.1016/S0169-409X(01)00245-9 ↗
30. 10.1016/S0927-7765(99)00080-610.1016/S0927-7765(99)00080-6 ↗
31. 10.1016/j.jconrel.2014.09.02010.1016/j.jconrel.2014.09.020 ↗
32. 10.1021/ja110468v10.1021/ja110468v ↗
33. 10.1016/j.biomaterials.2014.09.00810.1016/j.biomaterials.2014.09.008 ↗
34. 10.1038/nmat318710.1038/nmat3187 ↗
35. 10.1002/jbm.b.3351910.1002/jbm.b.33519 ↗
36. 10.1002/smll.20140139710.1002/smll.201401397 ↗
37. 10.1016/j.actbio.2015.05.02810.1016/j.actbio.2015.05.028 ↗
38. 10.1016/j.biomaterials.2013.09.00110.1016/j.biomaterials.2013.09.001 ↗
39. 10.1021/mp100298r10.1021/mp100298r ↗
40. 10.1016/j.actbio.2015.01.01910.1016/j.actbio.2015.01.019 ↗
41. 10.1002/adma.20140471510.1002/adma.201404715 ↗
42. 10.1039/c0py00406e10.1039/c0py00406e ↗
43. 10.1126/science.122956810.1126/science.1229568 ↗
44. 10.1016/j.jconrel.2012.04.04510.1016/j.jconrel.2012.04.045 ↗
45. 10.1371/journal.pone.012012910.1371/journal.pone.0120129 ↗
46. 10.1016/j.biomaterials.2014.06.02210.1016/j.biomaterials.2014.06.022 ↗
47. 10.1158/0008-5472.CAN-05-362710.1158/0008-5472.CAN-05-3627 ↗